Healthcare & Medical Devices Global On demand · 24-48h

Global Resorbable Bone Substitute Market Strategic Research Report

Global Resorbable Bone Substitute Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Resorbable Bone Substitute Market
$1.09B2025
6.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Ceramics, Hydroxyapatite, Polymer, Others

By Application: Orthopaedic, Dental

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Zimmer Biomet, Leaderbiomedical, Absorbable Artificial Bone, Swallow Dental, Tracxn, Teknimed, Ligamed Biomaterials Co, PuraGraft, Medtronic, Stryker Corporation, Geistlich Pharma, Biocomposites, DePuy Synthes (Johnson & Johnson), Baxter International Inc., Unicare Biomedical, XeliteMed, Corliber, Double Medical Technology, Shandong Weigao

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 143 pages
Market size 2025
$1.09B
Billion USD
Forecast CAGR
6.7%
2025-2032
Forecast 2032
$1.7B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Resorbable Bone Substitute market size is predicted to grow from US$ 1,091 million in 2025 to US$ 1,708 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

A resorbable bone substitute is a bioceramic material designed to act as a bone void filler in bony voids or gaps in the skeletal system (i.e. extremities, posterolateral spine, and pelvis). It can also be used for common dental procedures such as sinus lifts, periodontal bone filling, and filling of cystic or peri-implant defects. This product provides a bone void filler that is resorbed and replaced by bone during the healing process.

Bone graft substitutes are biological products that can replace autologous bone grafts. The substitutes consist of allograft bone, demineralized bone matrix, polymers, hydroxyapatite, and other materials. These substitutes are used in the treatment of bone defects, in union or non-union surgery, and in orthopedic spinal fusion. Moreover, various advantages of these substitutes, such as safety, biocompatibility, and osteoconductivity to fractures, have increased the applications of these products over the past decade.

The growth of the global bone grafts and substitutes market is attributed to the increasing incidence of bone diseases such as bone infections and bone tumors and increasing number of orthopedic procedures globally. Furthermore, rising demand for synthetic alternatives and surging number of products approved by various agencies are expected to drive market growth over the forecast period.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Resorbable Bone Substitute market?

What factors are driving Resorbable Bone Substitute market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Resorbable Bone Substitute market opportunities vary by end market size?

How does Resorbable Bone Substitute break out by Type, by Application?

This report presents a comprehensive overview of the global Resorbable Bone Substitute market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Ceramics
  • Hydroxyapatite
  • Polymer
  • Others

Segment by Application

  • Orthopaedic
  • Dental

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Resorbable Bone Substitute market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Orthopaedic, Dental evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Resorbable Bone Substitute Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.09B
2025
Forecast
$1.7B
2032
CAGR
6.7%
2025–2032
Области
5
global
Key companies
Zimmer BiometLeaderbiomedicalAbsorbable Artificial BoneSwallow DentalTracxnTeknimedLigamed Biomaterials CoPuraGraft
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
CeramicsHydroxyapatitePolymerOthers
By Application
OrthopaedicDental

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Ceramics
  • 3.1.3 Hydroxyapatite
  • 3.1.4 Polymer
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Orthopaedic
  • 4.1.3 Dental
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Zimmer Biomet
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Leaderbiomedical
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Absorbable Artificial Bone
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Swallow Dental
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Tracxn
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Teknimed
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Ligamed Biomaterials Co
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 PuraGraft
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Medtronic
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Stryker Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Geistlich Pharma
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Biocomposites
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 DePuy Synthes (Johnson & Johnson)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Baxter International Inc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Unicare Biomedical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 XeliteMed
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Corliber
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Double Medical Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Shandong Weigao
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Resorbable Bone Substitute market?
The global Resorbable Bone Substitute market is estimated at US$ 1.09 billion in 2025 (base year) and is projected to reach US$ 1.71 billion by 2032.
What is the forecast CAGR for the Resorbable Bone Substitute market?
The market is expected to grow at a CAGR of 6.7% from 2026 to 2032, expanding from US$ 1.09 billion in 2025 to US$ 1.71 billion in 2032, roughly 1.6 times its base-year value.
What is Resorbable Bone Substitute?
A resorbable bone substitute is a bioceramic material designed to act as a bone void filler in bony voids or gaps in the skeletal system (i.e. extremities, posterolateral spine, and pelvis). It can also be used for common dental procedures such as sinus lifts, periodontal bone filling, and filling of cystic or peri-implant defects. This product provides a bone void filler that is resorbed and replaced by bone during the healing process.
What are the main segments of the Resorbable Bone Substitute market by type?
By type, the market is segmented into Ceramics, Hydroxyapatite, Polymer and Others.
Which applications drive demand in the Resorbable Bone Substitute market?
Key applications covered include Orthopaedic and Dental.
Who are the key players in the Resorbable Bone Substitute market?
Key players profiled include Zimmer Biomet, Leaderbiomedical, Absorbable Artificial Bone, Swallow Dental, Tracxn, Teknimed, Ligamed Biomaterials Co and PuraGraft, among 19 companies covered in total.
Which regions and countries are covered for Resorbable Bone Substitute?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Resorbable Bone Substitute market?
What factors are driving Resorbable Bone Substitute market growth, globally and by region?
Who should buy the Resorbable Bone Substitute market report?
The report is intended for manufacturers and solution providers, distributors and end users in Orthopaedic and Dental, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Resorbable Bone Substitute market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.